British Prime Minister Boris Johnson wrote to European Council President Donald ...
LONDON - British Prime Minister Boris Johnson wrote to European Council President Donald Tusk on Monday to propose replacing the Irish backstop with a commitment to put in place alternative arrangements by the end of a post-Brexit transition period.
Johnson, who has promised to take Britain out of the EU on Oct. 31 with or without a deal, said that he believed it was possible to reach an agreement and that doing so was his government’s “highest priority”. The backstop would force Britain to obey some EU rules if no other way could be found to keep the land border open between British-ruled Northern Ireland and EU member Ireland. Dublin says this is crucial to maintaining peace on the island.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Boris Johnson to face EU leaders for Brexit talks as uncertainty roils UK marketsThe direction Brexit will take could become clearer this week as U.K. Prime Minister Boris Johnson prepares to meet his German and French counterparts.
Read more »
UK PM Johnson to deliver Brexit message to Macron, MerkelBritish Prime Minister Boris Johnson will deliver his message on Brexit to Frenc...
Read more »
Johnson to tell France and Germany that UK parliament cannot stop Brexit: TelegraphPrime Minister Boris Johnson will tell French President Emmanuel Macron and Germ...
Read more »
UK parliament cannot stop Brexit, Johnson to tell Macron and MerkelPrime Minister Boris Johnson will tell French President Emmanuel Macron and Germ...
Read more »
UK plans to end EU freedom of movement immediately in no-deal BrexitBritain said on Monday it would end European Union freedom of movement rules imm...
Read more »
Billionaire Backs U.K. Startup Trying To Extend Human LifespansMike Cannon-Brookes, the billionaire cofounder of Australian software giant Atlassian, has invested $10 million into Juvenescence, a U. K. biotech startup that’s trying to increase human longevity.
Read more »